התחל במצב לא מקוון עם האפליקציה Player FM !
Hemostemix Inc.
Manage episode 390216080 series 1342326
Hemostemix Inc. (OTCQB: HMTXF) is a patient's own stem cell therapy company that holds 91 patents. A winner of the World Economic Forum Technology Pioneer Award, the Company has developed patented, and is scaling a patient's blood-based stem cell therapeutics platform. Thomas Smeenk, President, CEO and Co-Founder of Hemostemix, joins us today to share his personal story and inspiration for creating this company to help others.
293 פרקים
Manage episode 390216080 series 1342326
Hemostemix Inc. (OTCQB: HMTXF) is a patient's own stem cell therapy company that holds 91 patents. A winner of the World Economic Forum Technology Pioneer Award, the Company has developed patented, and is scaling a patient's blood-based stem cell therapeutics platform. Thomas Smeenk, President, CEO and Co-Founder of Hemostemix, joins us today to share his personal story and inspiration for creating this company to help others.
293 פרקים
All episodes
×ברוכים הבאים אל Player FM!
Player FM סורק את האינטרנט עבור פודקאסטים באיכות גבוהה בשבילכם כדי שתהנו מהם כרגע. זה יישום הפודקאסט הטוב ביותר והוא עובד על אנדרואיד, iPhone ואינטרנט. הירשמו לסנכרון מנויים במכשירים שונים.